H.B. Fuller evaluates Ancora's $1.2B cash offer for BAS unit

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

H.B. Fuller has confirmed receipt of its first formal unsolicited proposal from Ancora Holdings Group to acquire its Building Adhesives Solutions business for $1.1B-$1.2B in cash. The board will evaluate the offer alongside advisors, while analysts maintain a Buy consensus with an average target of $71.25 ahead of the September earnings update.

powered bylight_fuzz_icon
48100813

*this image is generated using AI for illustrative purposes only.

H.B. Fuller Company (NYSE: FUL), the largest pureplay adhesives company, confirmed receipt of an unsolicited proposal from activist investor Ancora Holdings Group to acquire its Building Adhesives Solutions (BAS) business for between $1.1 billion and $1.2 billion in cash. Although Ancora previously expressed passing verbal interest in the BAS segment, this letter represents the first formal offer received by the adhesives manufacturer for the division.

Deal Dynamics

Ancora privately approached H.B. Fuller President and CEO Celeste Mastin and board chair Rasmussen on July 7, 2026, but stated it did not receive a substantive response. Consequently, the activist fund made the proposal public, outlining terms that exclude financing contingencies. Ancora indicated it is prepared to sign a confidentiality agreement and begin due diligence immediately.

H.B. Fuller’s management team and Board of Directors regularly review the company’s portfolio to maximize shareholder value creation. Consistent with that focus, the Board will carefully evaluate the proposal in consultation with its financial and legal advisors.

The shareholder argued that selling the Building Adhesive Solutions business would enable H.B. Fuller to exit a fragmented market and continue executing Project Quantum Leap. The firm added that it could raise its proposed price if the review identifies additional value in the business.

Proposal Detail Status
Offer Value $1.1 billion to $1.2 billion cash
Target Segment Building Adhesive Solutions
Contingencies No financing contingency
Approval Needs Board, shareholder, regulatory clearances

The proposal is non-binding and remains subject to confirmatory due diligence, board and any required shareholder approvals, regulatory and third-party clearances, and the negotiation of a definitive agreement. Ancora has asked H.B. Fuller’s independent directors to indicate whether the company is willing to explore a deal. It also reserved the right to modify or withdraw the proposal before a binding agreement is signed.

Market Reaction

H.B. Fuller shares fell on Wednesday following the news, closing down 1.41% at $61.16. The decline occurred during a mixed session in which the S&P 500 gained about 0.2%, while the Materials sector fell roughly 0.9%.

Technically, the stock is trading above its 20-day simple moving average (SMA) of $57.71 by about 6.1%. However, bearish signals persist with the 50-day SMA below the 200-day SMA, indicating a death cross that occurred in July. Momentum indicators reveal that the moving average convergence divergence (MACD) is above its signal line, suggesting downside pressure is easing.

Key resistance sits at $66.50, while key support is at $55.00.

Earnings Preview And Analyst Views

H.B. Fuller Company is slated to provide its next financial update on September 23, 2026 (estimated). Analysts estimate earnings per share of $1.47, up from $1.26, and revenue of $946.63 million, up from $892.04 million. The stock carries a valuation P/E of 18.4x, which analysts indicate as fair valuation.

The consensus rating remains Buy with an average price forecast of $71.25. Recent analyst actions include:

  • Citigroup: Buy (Raises Target to $75.00) (June 30)
  • Deutsche Bank: Buy (Raises Target to $72.00) (June 30)
  • JP Morgan: Upgraded to Overweight (Raises Target to $67.00) (June 26)

How might the potential divestiture of the Building Adhesives Solutions segment impact H.B. Fuller's valuation multiples and ability to execute Project Quantum Leap?

What is the likelihood that Ancora Holdings will increase its offer price above $1.2 billion if H.B. Fuller's due diligence reveals higher-than-expected synergies or asset value?

Could the rejection or acceptance of this unsolicited proposal trigger further activist campaigns targeting other non-core segments of H.B. Fuller's portfolio?

like20
dislike

H.B. Fuller declares $0.2450 quarterly dividend

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

H.B. Fuller's Board of Directors declared a regular quarterly cash dividend of $0.2450 per share, payable on August 13, 2026 to shareholders of record on July 30, 2026. The company has paid quarterly cash dividends on its common stock for 58 consecutive years.

powered bylight_fuzz_icon
45767700

*this image is generated using AI for illustrative purposes only.

H.B. Fuller Company’s Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable on August 13, 2026 to shareholders of record at the close of business on July 30, 2026. This announcement continues the company's long-standing practice of returning capital to shareholders.

H.B. Fuller has paid quarterly cash dividends on its common stock for 58 consecutive years. The company operates as the largest pureplay adhesives company in the world, providing innovative functional coatings, adhesives, and sealants.

Key Dividend Details

Detail Information
Dividend per share $0.2450
Record date July 30, 2026
Payment date August 13, 2026

Founded in 1887, H.B. Fuller reported 2025 revenue of $3.5 billion. The company employs more than 7,100 global team members who collaborate with customers across more than 30 market segments in 150 countries.

How sustainable is the current dividend payout ratio given the projected revenue growth for fiscal 2026?

What impact will raw material inflation have on H.B. Fuller's ability to maintain dividend increases in the coming fiscal year?

Are there plans to shift capital allocation strategy towards share buybacks or acquisitions over continued dividend growth?

like16
dislike

More News on H.B. Fuller Co

Must Read Next

Corporate Actions

Aurobindo Pharma schedules analyst and investor meet on September 22 9 mins ago
Global Health schedules analyst and investor meetings on September 17 and 18 10 mins ago
KPIT Technologies schedules analyst and investor meetings on Sep 21 and 22 10 mins ago
no imag found